Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Holders of 5% or more of TAK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Takeda Pharmaceutical Co Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Takeda Pharmaceutical Co Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Takeda Pharmaceutical Co Ltd, newest first.
No Schedule 13D or 13G filings on Takeda Pharmaceutical Co Ltd are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Takeda Pharmaceutical Co Ltd shares.
No Form 144 notices for Takeda Pharmaceutical Co Ltd are on file.